Tool Preview
Lab Visualizer
This is a preview of the cooperative's tools, built with sample data for a fictional patient. The production platform will be adapted from open-source infrastructure. Lab values shown here are realistic but not from a real person.
Viewing labs for: Sample Member
Diagnosis Multiple myeloma, IgG kappa
Diagnosed January 2026, age 38
Current Status Maintenance therapy (lenalidomide)
Data Source Patient-directed collection via FHIR
Serum M-Protein
Tracks the abnormal protein produced by myeloma cells. A declining trend during treatment signals a response. Reference range for normal: below 0.3 g/dL.
Free Light Chains
Kappa and lambda light chains help monitor myeloma activity. The ratio between them is often the most sensitive marker. Normal kappa: 3.3 to 19.4 mg/L. Normal lambda: 5.7 to 26.3 mg/L.
Kappa/Lambda Ratio
The ratio between kappa and lambda free light chains. A normalizing ratio is a strong indicator of treatment response. Normal range: 0.26 to 1.65.
Hemoglobin
Measures oxygen-carrying capacity. Myeloma and chemotherapy often lower hemoglobin. Recovery during maintenance is a positive sign. Normal range: 13.5 to 17.5 g/dL.
White Blood Cells (WBC)
Tracks immune system capacity. Treatment cycles and transplant cause expected dips. Normal range: 4.5 to 11.0 × 10³/μL.
Platelets
Essential for blood clotting. Chemotherapy temporarily reduces platelet counts. Recovery is expected during maintenance. Normal range: 150 to 400 × 10³/μL.
M-Protein (g/dL)
Kappa FLC (mg/L)
Kappa/Lambda Ratio
Hemoglobin (g/dL)
WBC (× 10³/μL)
Platelets (× 10³/μL)
Treatment Timeline
Your labs, your view.
As a founding member, you'll connect your own lab results through our secure platform. You control what's shared, with whom, and for how long.
Become a founding member